Author

Susan Apkon

Observed names: Apkon S, S Apkon, susan apkon

Institutions: Children's Hospital Colorado, University of Colorado Anschutz, University of Colorado Denver

Observed institutions: Children's Hospital Colorado, University of Colorado Anschutz, University of Colorado Denver

ORCID: 0009-0008-9873-7970

Observed ORCID: 0009-0008-9873-7970

OpenAlex ID: A5136355376

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial

2026 · Craig M McDonald, Chet Villa, et al. · The Lancet · 2

Caring for Gender Diverse Youth With Duchenne Muscular Dystrophy: A Multisite Case Series

2026 · Carlos E. Melendez Garcia, Usman A. Ahmed, et al. · Pediatric Neurology · 2

Navigating sexual health, fertility, and adult wellness in individuals with Duchenne muscular dystrophy: Current standards of care and future directions

2026 · Nat Nasomyont, Amanda Appel, et al. · Journal of Neuromuscular Diseases · 1

Optimizing Care for Growth and Puberty in Duchenne Muscular Dystrophy: A Survey of Clinical Practice in the OPTIMIZE DMD Consortium

2026 · Claire L. Wood, Funmbi Babalola, et al. · Muscle & Nerve · 1

4.63eP Impact of local neuromuscular clinic access on patient travel distance, costs, and work loss: A case for a community clinic’s role in multidisciplinary care

2026 · Elizabeth Lynne Wood, Susan Apkon · Neuromuscular Disorders

2.30eP Development and validation of a novel dystrophinopathy foot index (DFI) for comparison and surgical decision-making related foot contracture

2026 · Meghan Moore Burk, Amanda Appel, et al. · Neuromuscular Disorders

2.88P Zeleciment rostudirsen increased dystrophin protein levels and demonstrated functional improvement in clinical measures in the DELIVER trial

2026 · Ian Woodcock, Susan Apkon, et al. · Neuromuscular Disorders

4.72eP Leveraging partnerships between small and large care centers to provide telehealth consultation improves access and equity

2026 · Elizabeth Lynne Wood, Susan Apkon · Neuromuscular Disorders

Adrenal insufficiency in individuals with Duchenne muscular dystrophy treated with glucocorticoids: Insights from the past, current challenges, and future directions

2026 · David R. Weber, Alexandra Ahmet, et al. · Journal of Neuromuscular Diseases

A structured approach to address variability in the global management of adrenal insufficiency in Duchenne muscular dystrophy: the 2025 PJ Nicholoff steroid protocol

2026 · Anne Marie Sbrocchi, Alexandra Ahmet, et al. · Frontiers in Neurology

Understanding Discordant Board Outcomes

2026 · Sherilyn W. Driscoll, Mikaela M. Raddatz, et al. · American Journal of Physical Medicine & Rehabilitation

Postural Torticollis and Early‐Onset Scoliosis in Infants With SMA Identified Through Newborn Screening: Single Institution Experience

2026 · Meghan Moore Burk, Carolyn Kelley, et al. · Muscle & Nerve

Deramiocel Significantly Slows Upper Limb Functional Decline in Duchenne Muscular Dystrophy: Skeletal Muscle Outcomes from the Phase 3 HOPE-3 Trial (LS2.003)

2026 · Susan Iannaccone, Craig McDonald, et al. · Neurology

B61-03 Oscillometry and Spirometry in Ambulatory and Non-Ambulatory People With Dystrophinopathy

2026 · M Mccoy, E C Meneses, et al. · American Journal of Respiratory and Critical Care Medicine

Adrenal Suppression in Duchenne Muscular Dystrophy: Management Strategies Incorporating Novel Steroid Vamorolone

· Sbrocchi AM, Kinnett K, et al. · Newcastle University ePrints (Newcastle Univesity)

Works count: 15

Citation count: 6

H-index: 2

I10-index: